Back

Mirabegron in peripheral vascular disease: the STAR-PAD trial.

28 August 2022 (17:15 - 17:30)
Organised by:
Congress Presentation Part of: Beta3 adrenergic agonists in the clinic: the end of the beginning Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Michael Gray

University of Sydney, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail
Beta3 adrenergic receptors: where, and what for?
Professor J. Balligand (Brussels, BE)
Slides Video
Presentation thumbnail
Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.
Associate Professor R. Wachter (Leipzig, DE)
Slides Video
Presentation thumbnail
Mirabegron in patients with pulmonary hypertension: the SPHERE-HF trial.
Doctor A. Garcia-Alvarez (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
Beta3 adrenergic agonists in the clinic: the end of the beginning
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Session
Cardiovascular and limb outcomes in peripheral artery disease
29 August 2025
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
27 August 2023
thumbnail
Congress Session
HOT LINE 4
30 August 2025
thumbnail
Congress Presentation
Semaglutide promotes vascular repair mechanisms
31 August 2025

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources